Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foxboro, originally known as The Foxboro Company and now a premier brand under Schneider Electric, is a global leader in industrial automation and process control systems. While not a biotechnology or pharmaceutical developer itself, the company is a critical infrastructure provider for the life sciences industry, offering advanced distributed control systems (DCS), measurement instrumentation, and automation software. Its technologies are widely utilized in the manufacturing of pharmaceuticals and biologics to ensure precise process control, regulatory compliance, and operational efficiency. Foxboro's solutions, such as the EcoStruxure Foxboro DCS, are designed to meet the stringent requirements of Good Manufacturing Practice (GMP) environments. The company's expertise spans across various sectors, including chemical processing, oil and gas, and power generation, in addition to its significant footprint in healthcare manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foxboro.